Santiago Arroyo

2017

In 2017, Santiago Arroyo earned a total compensation of $2.3M as Senior Vice President, Development and Chief Medical Officer at Momenta Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$144,320
Option Awards$1,291,065
Salary$257,231
Stock Awards$619,200
Other$9,213
Total$2,321,029

Arroyo received $1.3M in option awards, accounting for 56% of the total pay in 2017.

Arroyo also received $144.3K in non-equity incentive plan, $257.2K in salary, $619.2K in stock awards and $9.2K in other compensation.

Rankings

In 2017, Santiago Arroyo's compensation ranked 4,794th out of 14,666 executives tracked by ExecPay. In other words, Arroyo earned more than 67.3% of executives.

ClassificationRankingPercentile
All
4,794
out of 14,666
67th
Division
Manufacturing
1,699
out of 5,768
71st
Major group
Chemicals And Allied Products
501
out of 2,074
76th
Industry group
Drugs
386
out of 1,730
78th
Industry
Biological Products, Except Diagnostic Substances
71
out of 316
78th
Source: SEC filing on April 27, 2018.

Arroyo's colleagues

We found five more compensation records of executives who worked with Santiago Arroyo at Momenta Pharmaceuticals in 2017.

2017

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2017

Matthew Ottmer

Momenta Pharmaceuticals

Chief Operating Officer

2017

Ganesh Kaundinya

Momenta Pharmaceuticals

Chief Operating Officer

2017

Bruce Leicher

Momenta Pharmaceuticals

General Counsel

2017

Scott Storer

Momenta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like